BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 16309541)

  • 1. Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.
    Thomas GR; Nadiminti H; Regalado J
    Int J Exp Pathol; 2005 Dec; 86(6):347-63. PubMed ID: 16309541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression analysis of head and neck squamous cell carcinoma survival and recurrence.
    Zhi X; Lamperska K; Golusinski P; Schork NJ; Luczewski L; Kolenda T; Golusinski W; Masternak MM
    Oncotarget; 2015 Jan; 6(1):547-55. PubMed ID: 25575813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of miRNA in head and neck squamous cell carcinoma.
    Masood Y; Kqueen CY; Rajadurai P
    Expert Rev Anticancer Ther; 2015 Feb; 15(2):183-97. PubMed ID: 25367254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
    Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
    Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.
    Michalides R; van Veelen N; Hart A; Loftus B; Wientjens E; Balm A
    Cancer Res; 1995 Mar; 55(5):975-8. PubMed ID: 7867006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into metastatic roadmap of head and neck cancer squamous cell carcinoma based on clinical, histopathological and molecular profiles.
    Mastronikolis NS; Delides A; Kyrodimos E; Piperigkou Z; Spyropoulou D; Giotakis E; Tsiambas E; Karamanos NK
    Mol Biol Rep; 2024 Apr; 51(1):597. PubMed ID: 38683372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podoplanin is involved in the prognosis of head and neck squamous cell carcinoma through interaction with VEGF-C.
    Kim HY; Rha KS; Shim GA; Kim JH; Kim JM; Huang SM; Koo BS
    Oncol Rep; 2015 Aug; 34(2):833-42. PubMed ID: 26081937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
    Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
    Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot.
    Yoo GH; Piechocki MP; Ensley JF; Nguyen T; Oliver J; Meng H; Kewson D; Shibuya TY; Lonardo F; Tainsky MA
    Clin Cancer Res; 2002 Dec; 8(12):3910-21. PubMed ID: 12473607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck.
    Ginos MA; Page GP; Michalowicz BS; Patel KJ; Volker SE; Pambuccian SE; Ondrey FG; Adams GL; Gaffney PM
    Cancer Res; 2004 Jan; 64(1):55-63. PubMed ID: 14729608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
    Chung CH; Parker JS; Ely K; Carter J; Yi Y; Murphy BA; Ang KK; El-Naggar AK; Zanation AM; Cmelak AJ; Levy S; Slebos RJ; Yarbrough WG
    Cancer Res; 2006 Aug; 66(16):8210-8. PubMed ID: 16912200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA copy number variation and loss of heterozygosity in relation to recurrence of and survival from head and neck squamous cell carcinoma: a review.
    Chen Y; Chen C
    Head Neck; 2008 Oct; 30(10):1361-83. PubMed ID: 18642290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
    Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
    Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease.
    Gollin SM
    Genes Chromosomes Cancer; 2014 Dec; 53(12):972-90. PubMed ID: 25183546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression signatures and molecular markers associated with clinical outcome in locally advanced head and neck carcinoma.
    Pavón MA; Parreño M; Téllez-Gabriel M; Sancho FJ; López M; Céspedes MV; Casanova I; Lopez-Pousa A; Mangues MA; Quer M; Barnadas A; León X; Mangues R
    Carcinogenesis; 2012 Sep; 33(9):1707-16. PubMed ID: 22696598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
    Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma.
    Graveland AP; Golusinski PJ; Buijze M; Douma R; Sons N; Kuik DJ; Bloemena E; Leemans CR; Brakenhoff RH; Braakhuis BJ
    Int J Cancer; 2011 Apr; 128(8):1852-9. PubMed ID: 20568113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
    Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gene expression profile of inflammatory, hypoxic and metabolic genes predicts the metastatic spread of human head and neck squamous cell carcinoma.
    Clatot F; Gouérant S; Mareschal S; Cornic M; Berghian A; Choussy O; El Ouakif F; François A; Bénard M; Ruminy P; Picquenot JM; Jardin F
    Oral Oncol; 2014 Mar; 50(3):200-7. PubMed ID: 24387976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.